Mallinckrodt Stock Price

-0.03 (-1.19%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Mallinckrodt Plc MNK NYSE Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.19 8.12% 2.53 2.26 2.5485 2.28 2.34 20:00:00
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
11,127 3,816,677 $ 2.47 $ 9,435,061 3,658,548 1.00 - 8.77
Last Trade Time Type Quantity Stock Price Currency
19:42:08 1 $ 2.50 USD

Mallinckrodt Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 213.67M 84.46M 83.19M $ 3.16B $ -1.70B -11.89 -0.13
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
44.65M $ - 0.00% - -

more financials information »

Mallinckrodt News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MNK Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week2.492.702.262.412,324,9240.041.61%
1 Month2.662.982.252.673,036,318-0.13-4.89%
3 Months3.454.242.253.074,338,110-0.92-26.67%
6 Months3.177.451.003.586,895,339-0.64-20.19%
1 Year8.638.771.003.467,354,116-6.10-70.68%
3 Years42.5349.121.0011.124,253,436-40.00-94.05%
5 Years122.25127.001.0024.053,420,446-119.72-97.93%

Mallinckrodt Description

Mallinckrodt PLC develops, manufactures, markets and distributes specialty pharmaceutical products and therapies. Its areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, nephrology, pulmonology and ophthalmology; immunotherapy and neonatal respiratory critical care therapies; analgesics and gastrointestinal products. The company operates its business in two reportable segments namely Specialty Brands that includes innovative specialty pharmaceutical brands; and Specialty Generics that includes niche specialty generic drugs and active pharmaceutical ingredients.
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200711 12:28:33